Depression is associated with poorer recover after traumatic brain injury (TBI), yet awareness of depression risk post-TBI among providers and patients is low. The aim of this study was to estimate risk of depression post-TBI among adults 18 years of age and older and to identify risk factors associated with developing depression post-TBI. We conducted a retrospective, matched cohort study using claims data for privately insured and Medicare Advantage enrollees in a large U.S. health plan. Adults ≥18 years of age diagnosed with TBI (n = 207,354) with 12 months continuous insurance coverage pre-TBI and 24 months post-TBI were matched to controls without TBI (n = 414,708). We identified the presence of depression on any in- or outpatient claim occurring during the study period (both before and after TBI). Of the initial 622,062 individuals, 62,963 (10%) had depression pre-TBI and were excluded from incidence calculations. Incidence of depression post-TBI was 79.5 (95% confidence interval [CI], 78.5,80.5) per 1,000 person-years compared to 33.5 (95% CI, 33.1,34.0) per 1,000 person-years for those without TBI. The adjusted hazard ratio for depression post-TBI was 1.83 (95% CI, 1.79,1.86). We observed effect modification by sex and age, with males and older adults at increased risk. History of neuropsychiatric disturbances pre-TBI was the strongest predictor of depression post-TBI. Risk of depression increases substantially post-TBI. Groups at increased risk include those with a history of neuropsychiatric disturbances, older adults, and men. This study highlights the importance of long-term monitoring for depression post-TBI.
Objectives: Depression is a leading cause of global burden of disease. Depression in high risk group needs special attention. Depression among fathers of a newborn (Paternal Postnatal Depression) is not commonly identified as depression among mothers (Maternal Postpartum Depression) of a newborn. However, both maternal and paternal depression during postpartum period can impact child development. The aim of this study is to estimate the prevalence rate of paternal postnatal depression among fathers of a newborn in Saudi Arabia. MethOds: This is a cross-section study of fathers who received a newborn baby within 6 months at the time of participation in the survey. Participants were selected using systematic sampling of fathers visiting birth registration office. Two hundred ninety participants were screened using validated self-administered Arabic version of Edinburgh Postnatal Depression Scale (EPDS). Participants with EPDS score of 9 or above were considered to have depression. Demographic characteristics were summarized and reported in terms of mean, standard deviation and proportion. Both apparent and sensitivity/ specificity adjusted prevalence were calculated and reported in terms of point estimate and corresponding Wilson 95% confidence interval. Analyses were carried out using SAS version 9.4. Results: Among the 290 participating fathers, the average age was 34.97±8.56 years, with the reported average age of spouse was 29.18±7.41 years, and the newborns baby's age was 43.13±35.88 days. 184(73.3%) fathers had prior children and median number of children living in house was 3(3.0). 141(50.9%) fathers had higher education. 263(94.27%) were employed and 218(83.2%) reported to have full time job. Only 78(28.36%) had own a home. 261(92.55%) were married to one wife. 159(55.9%) had planned pregnancy. The overall apparent prevalence of paternal postnatal depression was 27.9%, 95% CI (23.1, 33.3). However, adjusted prevalence was 16.6%, 95% CI (8.5, 25.6). cOnclusiOns: Men mental health needs equal attention as women during and post-delivery of the newborn.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.